falsefalse

Integrating Hepatic Artery Infusion Therapy into Treatment Regimens for Colorectal Cancer Liver Metastases and Intrahepatic Cholangiocarcinoma: Expert Perspectives - Episode 4

Data in Resected Colorectal Cancer Liver Metastases

,

Louise Catherine Connell, MB BCh BAO, BMedSc, and Ryan Merkow, MD, MS, review clinical trial data on resected colorectal cancer liver metastases.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Unmet Needs in Colorectal Cancer Liver Metastases
    EP. 2: Hepatic Artery Infusion Background
    EP. 3: Hepatic Artery Infusion Data in Unresectable Colorectal Cancer Liver Metastases
    Now Viewing
    EP. 4: Data in Resected Colorectal Cancer Liver Metastases
    EP. 5: Unmet Needs and Clinical Data with Hepatic Artery Infusion in Intrahepatic Cholangiocarcinoma
    EP. 6: Hepatic Artery Infusion in Practice
    EP. 7: Case Studies with Hepatic Artery Infusion

    Related Content:

    Integrating Hepatic Artery Infusion Therapy into Treatment Regimens for Colorectal Cancer Liver Metastases and Intrahepatic Cholangiocarcinoma: Expert PerspectivesUniversity of Chicago Medicine Comprehensive Cancer CenterMemorial Sloan Kettering Cancer Center Gastrointestinal CancerInsights
    Early-Phase RAS Inhibitor Research Sparks Interest in NSCLC: With Kathryn C. Arbour, MD
    Giants of Cancer Care® Announces the 13th Annual Class of Inductees
    Dr Harding on the FDA Approval of Nivolumab Plus Ipilimumab for Unresectable or Metastatic HCC
    x